Clinical Study
The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era
| Clinical Factors | Adjusted Hazard Ratio | 95% CI | P |
| Age (years old) | 0.97 | 0.90-1.04 | 0.359 | BMI (≥23kg/m2) | 1.68 | 0.40-6.94 | 0.477 | Gender (male) | 2.39 | 0.38-14.95 | 0.351 | Previous PCI | 9.43 | 2.58-34.52 | 0.001 | Diabetes mellitus | 1.56 | 0.47-5.21 | 0.472 | Hypertension | 0.87 | 0.25-3.11 | 0.835 | CRF | 1.45 | 0.30-7.04 | 0.641 | Dyslipidemia | 0.70 | 0.20-2.48 | 0.579 | Current smoking | 2.56 | 0.78-8.40 | 0.122 | FHx of CAD | NA | NA | 0.974 | LV dysfunction (<40%) | NA | NA | 0.988 | Multivessel disease | 0.42 | 0.12-1.41 | 0.159 | Hemoglobin (g/dl) | 1.19 | 0.77-1.85 | 0.429 | CRP (mg/dl) | 1.60 | 1.28-2.00 | <0.001 | Type B2/C lesion | 0.22 | 0.04-1.11 | 0.067 | Reference vessel diameter (mm) | 0.82 | 0.31-2.21 | 0.696 | Lesion length (mm) | 1.03 | 0.99-1.08 | 0.165 | Pre-procedure DS (%) | 0.97 | 0.94-1.08 | 0.142 | Post-procedure DS%, in- stent (mm) | 1.01 | 0.95-1.08 | 0.703 |
|
|
TLR, target lesion revascularization; CI, confidence interval; BMI, body mass index; PCI, percutaneous coronary intervention; CRF, chronic renal failure; FHx, family history; CAD, coronary artery disease; LV, left ventricle; CRP, C-reactive protein; DS, diameter stenosis.
|